Literature DB >> 12021957

Proximal myopathy and diffuse white matter involvement in myotonic dystrophy type I.

Kayihan Uluc, E Murat Arsava, Sevim Erdem, Ersin Tan.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12021957     DOI: 10.1007/s004150200076

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Central nervous system magnetic resonance imaging findings in myotonic dystrophy.

Authors:  R H Glantz; R B Wright; M S Huckman; D C Garron; I M Siegel
Journal:  Arch Neurol       Date:  1988-01

Review 2.  Clinical and genetic heterogeneity in myotonic dystrophies.

Authors:  G Meola
Journal:  Muscle Nerve       Date:  2000-12       Impact factor: 3.217

3.  Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study.

Authors:  A Ogata; S Terae; M Fujita; K Tashiro
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

4.  Proximal myotonic myopathy with MRI white matter abnormalities of the brain.

Authors:  E Hund; O Jansen; M C Koch; K Ricker; W Fogel; N Niedermaier; M Otto; E Kuhn; H M Meinck
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

5.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats.

Authors:  L Chang; T Ernst; D Osborn; W Seltzer; M Leonido-Yee; R E Poland
Journal:  Arch Neurol       Date:  1998-03

6.  Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests.

Authors:  L Chang; T Anderson; O A Migneco; K Boone; C M Mehringer; J Villanueva-Meyer; N Berman; I Mena
Journal:  Arch Neurol       Date:  1993-09

7.  Decreased cerebral glucose utilization in myotonic dystrophy.

Authors:  M Fiorelli; D Duboc; B M Mazoyer; J Blin; B Eymard; M Fardeau; Y Samson
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

  7 in total
  1 in total

1.  Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.

Authors:  N C Voermans; R C van der Bilt; J IJspeert; J Y Hogrel; M Jeanpierre; A Behin; P Laforet; T Stojkovic; B G van Engelen; G W Padberg; S Sacconi; R J L F Lemmers; S M van der Maarel; B Eymard; G Bassez
Journal:  J Neurol       Date:  2019-08-31       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.